... /Rats/ fed (14)C-labeled 1,2-dichloropropane & both isomers of 1,3-dichloropropene ... /showed/ differences in their metabolism. With all cmpd 80 to 90% of radioactivity was eliminated in first 24 hr. Major route of excretion of radioactivity was in urine, where 50.2, 80.7 & 56.5% of 1,2-dichloropropane, cis-1,3-dichloropropene, & trans-1,3-dichloropropene activity were found, respectively. The amount of (14)C-carbon dioxide exhaled was quite different for the two isomers. The cis-isomer yielded only 3.9% of dose & trans-isomer 23.6%, with correspondingly less in the radioactivity in the urine. As expected with volatile cmpd, residual unreacted cmpd were not present as significant residues, although metabolites entered the normal metabolic pool. Subsequently ... /it was shown/ that 82-84% of the radioactivity of (14)C labeled on the second carbon was recovered in the urine of rats as N-acetyl-S-((cis)-3-chloroprop-2-enyl) cysteine.
IDENTIFICATION: The technical mixture of dichloropropenes and dichloropropane is a clear amber liquid with a pungent odor. It is soluble in halogenated solvents, esters, and ketones. It was widely used as a soil nematocide before planting. HUMAN EXPOSURE: Dichloropropane-Dichloropropene mixture is no longer widely used and, thus, exposure of the general population via air, water, and food is unlikely. One case of acute fatal poisoning has been reported following accidental ingestion. Several cases of contact dermatitis and skin sensitization have been reported. ANIMAL STUDIES: The acute toxicity of dichloropropane-dichloropropene mixture for laboratory animals is moderate to high. Acute exposure results in clinical signs associated with central nervous system depression. It is a severe eye and skin irritant and it is a moderate dermal sensitizer. In a long-term study on rats fed diets containing up to 120 mg of the mixture per kg for 2 years, no toxic or carcinogenic effects were seen. No metabolic studies have been carried out on dichloropropane-dichloropropene mixture. The two major components, 1,2-dichloropropene and 1,2-dichloropropane, are rapidly eliminated, primarily in the urine and, to a lesser extent, via expired air. The components of the mixture are metabolized by oxidative and conjunction pathways. The major urinary metabolites are mercapturic acids.
1. FLUSH contaminating fumigants from the skin and eyse with copious amounts of water or saline for at least 15 minutes. Some fumigants are corrosive to the cornea and may cause BLINDNESS. Specialized medical treatment should be obtained promptly following removal of toxicant by copious flushing with clean water. Skin contamination may cause BLISTERING and deep chemical burns. Absorption of some fumigants across the skin may be sufficient to cause systemic poisoning in the absence of fumigant inhalation. For all these reasons, decontamination of eyes and skin must must be IMMEDIATE and THROUGH. 2. REMOVE victims of fumigant inhalation to FRESH AIR immediately. Even though initial symptoms and signs are mild, keep the victim quiet, in a semi-reclining position. Minimum pohysical activity limits the likehood ofpulmonary edema. 3. If victim is not breathing, clear the airway of secretions and RESUSCITATE with positive poressure oxygen apparatus. If this is not available, use chest compression to sustain respiration. If victim is pulseless, employ cardiac resuscitation. 4. If PULMONARY EDEMA is evident, there are several measures avilable to sustain life. Medical judgement must be relied upon, however, in the management of each case. The following procedures are generally recommended: A. Put the victim in a SITTING position with a backrest. B. Use intermittent and/or continuous positive pressure OXYGEN to relieve hypoxemia. ... C. Slowly administer FUROSEMIDE, 40 mg, or SODIUM ETHACRYNATE, 50 mg, to reduce venous load by inducing diuresis. ... D. Morphine in small doses (5-10 mg), slowly, iv to allay anxiety and promote deeper respiratory excursions. E. Administer AMINOPHYLLINE (0.25-0.50 gm) slowly, iv. ... F. Digitalization may be considered, but there is a serious risk of arrhythmias in an anoxic and toxic myocardium. G. TRACHEOSTOMY may be necessary in some cases to facilitate aspiration of large amounts of pulmonary edema fluid. H. Epinephrine, atorpine, and expectorants are generally not helpful, and may complicate treatment. I. Watch for RECURRENT PULMONARY EDEMA, even up to 2 weeks after the initial episode. Limit victim's physical activity for at least 4 weeks. Severe physical weakness usually indicates persistent pulmonary injury. Serial pulmonary function testing may be useful in assessing recovery. 5. Combat SHOCK by placing victim in the Trendelenburg position and administering plasma, whole blood, and/or electrolyte and glucose solutions intravenously, with great care, to avoid pulmonary edema. Central venous pressure should be monitored continously. Vasopressor amines must be given with great caution, because of the irritability of the myocardium. 6. Control CONVULSIONS. Seizures are most likely to occur in poisonings by methyl bromide, hydrogen cyanide, acrylonitrile, phosphine, and carbon disulfide. ... /Fumigant poisoning/
7. If a FUMIGANT LIQUID OR SOLID has been INGESTED less than several hours prior to treatment, quantities remaining in the stomach must be removed as effectively as possible by gastric intubation, aspiration, and lavage, after all possible precautions have been taken to protect the respiratory tract from aspirated gasric contents. A. Put in place a cuffed ENDOTRACHEAL TUBE prior to gastric intubation. Administer OXYGEN, using a mechanical ventilator if respiration is depressed. B. Lavage the stomach with a slurry of ACTIVATED CHARCOAL in saline or water. Leave a volume of the slurry in the stomach with an appropriate dose of sorbitol as cathartic ... . C. If treatment is delayed and if the patient remains fully alert, adminsiter activated charcoal and sorbitol orally. ... Repeated administration of charcoal at half or more the initial dosage every 2-4 hours may be beneficial. D. Do not given vegetable or animal fats or oils, which enhance gastrointestinal absorption of many of the fumigant compounds. 8. Intravenous infusions of GLUCOSE are valuable in limiting the heptotoxicity of many substances. Monitor central venous presure to avoid precipitating, or aggravating, pulmonary edema by fluid overlaod. The victim should be watched closely for indications of delayed or recurrent pulmonary edema, and for bronchophenumonia. Fluid balance should be monitored, and urine sediment should be checked regularly for indications of tubular injury. Measure serum alkaline phosphatase, LDH, ALT, AST, and bilirubin to assess liver injury. 9. HEMOPERFUSION OVER ACTIVATED CHARCOAL has been used in managing a case of carbon tetrachloride poisoning with apparent success. ... 10. EXTRACORPOREAL HEMODIALYSIS may be needed to regulate extracellular fluid composition if renal failure supervenes. It is probably not very effective in removing lipophilic fumigant compounds from blood, but is, of course, effective in controlling extracellular fluid composition if renal failure occurs. /Fumigant poisoning/
Stabilization: Treatment is largely supportive. Watch for respiratory depression & arrhythmias. Obtain arterial blood gases. Administer oxygen if there is evidence of altered mental status or dyspnea. Treat hypotension with volume expansion & vasopression. Use lidocaine or beta-blockers for ventricular arrhythmias. Skin: Remove contaminated clothing. Wash affected area with soap & copious amounts or water. Eye: Irrigate the eye for 15-20 min. Obtain a consultation if symptoms persist. Oral: Most of the halogenated solvents ingested in quantities of 1-2 swallows may be partially removed by ipecac-induced emesis if admin within a few hr to a patient who has not lost the gag reflex, is not seizing, is not markedly lethargic, or is not in coma. Observe the patient in the upright position to lessen the possibility of aspiration. Activated charcoal is probably ineffective. Inhalation: Move from the contaminated area. Provide a source of oxygen & prepare for mechanical ventilation. If the patient is unconscious & the pulse is absent, initiate CPR measures. Enhancement of Elimination: Maintain good ventilation. Hemodialysis or hemoperfusion are not likely to be useful because of the high lipophilic properties of these solvents. Antidote: N-acetylcysteine may restore depleted glutathione stores, but no adequate clinical studies are available to validate this possible treatment. Supportive Care: Watch for cardiac dysrhythmias, aspiration pneumonitis, hepatotoxicity, & hypoxic encephalopathy. Monitor for arrhythmia for at least 24 hr & for hepatorenal failure for about 3 days. Obtain a chest x-ray, arterial blood gas, EKG, serum creatinine, & hepatic aminotransferase. Check electrolyte imbalance daily. Treat renal failure with dialysis & hepatic failure with fresh frozen plasma, vitamin K, a low-protein diet, neomycin, & lactulose. Watch fluid & electrolyte balance. /Halogenated hydrocarbons/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
人类毒性摘录
该混合物对皮肤有严重刺激性。目前没有具体信息关于对眼睛的有害性,但已知其蒸气会刺激眼睛和上呼吸道。
The mixture is severely irritating to the skin. Specific information is not available on injuriousness to the eye, but the vapor is known to irritate the eyes & upper respiratory tract.
... With all cmpd 80 to 90% of radioactivity was eliminated in first 24 hr. Major route of excretion of radioactivity was in urine, where 50.2, 80.7 & 56.5% of 1,2-dichloropropane, cis-1,3-dichloropropene, & trans-1,3-dichloropropene activity were found, respectively. The amount of (14)C-carbon dioxide exhaled was quite different for the two isomers. The cis-isomer yielded only 3.9% of dose & trans-isomer 23.6%, with correspondingly less in the radioactivity in the urine.
METHODS AND COMPOSITIONS FOR TREATING PARASITIC WORM INFECTIONS IN A MAMMAL
申请人:MICROBES, INC.
公开号:US20130089530A1
公开(公告)日:2013-04-11
The invention relates to compositions for treating parasitic worm infections in a mammal. The composition includes an amount of intracellular components of lysed, beneficial, soil-inhabiting yeast cells sufficient to treat parasitic worm infections in a mammal; and/or an amount of whole or lysed soil-inhabiting bacteria cells, wherein the amount is sufficient to treat parasitic worm infections in a mammal, and optionally a pharmaceutically suitable carrier.
US5084477A
申请人:——
公开号:US5084477A
公开(公告)日:1992-01-28
US5185359A
申请人:——
公开号:US5185359A
公开(公告)日:1993-02-09
US6593299B1
申请人:——
公开号:US6593299B1
公开(公告)日:2003-07-15
[EN] METHOD FOR THE TREATMENT OF NEMATODES IN SOIL USING FURFURAL
申请人:GREAT LAKES CHEMICAL CORPORATION
公开号:WO1992008351A1
公开(公告)日:1992-05-29
(EN) A method for the treatment of nematodes includes applying to the nematodes in the soil a nematicidal amount of furfural. The furfural is preferably impregnated into the nematode-infested soil. The furfural may be applied neat or suspended in a variety of liquid or solid carrier systems, and is applied to the soil by methods including mixing, fumigation and injection. The furfural has excellent nematicidal effect at low concentrations, is cost effective, and is not phytotoxic.(FR) Le procédé décrit, qui sert à lutter contre la prolifération des nématodes, consiste à appliquer dans la terre contenant les nématodes une quantité nématicide de furfural, lequel est de préférence imprégné dans la terre infestée de nématodes. Le furfural peut être appliquer à l'état non dilué ou en suspension dans une grande variété de systèmes porteurs liquides ou solides et il est appliqué dans la terre par des procédés tels que le mélange, la fumigation et l'injection. Le furfural possède d'excellentes propriétés nématicides à des concentrations faibles, il a un bon rapport coût/efficacité et il n'est pas phytotoxique.